Hook & thesis
ASML is the machine behind the machines. The company reported an operational beat in Q1 and tightened guidance for 2026, signaling that the AI infrastructure cycle is translating into concrete orders for lithography and metrology systems. In a market that has rewarded AI supply-chain beneficiaries this year while creating headline volatility among hyperscalers, ASML stands out as an asset with durable competitive advantages and clearer revenue visibility.
My trade thesis: ASML is a buy from current levels for a position trade horizon because demand for EUV and advanced lithography remains tightly linked to hyperscaler capacity expansion and node migration. The company reported strong gross margins and raised full-year revenue expectations while returning capital via hikes to the dividend and share repurchases. Given the combination of structural pricing power, limited competition and visible buybacks, the market is still underestimating near-term upside - even after a big move higher.
What ASML does and why it matters
ASML develops, builds and services lithography systems that are the critical bottleneck in advanced semiconductor manufacturing. Its machines (EUV and deep ultraviolet) are required to pattern the most advanced chips. Because of technological complexity, multi-year R&D lead times and high switching costs, ASML operates a quasi-duopoly in the most advanced segment of the equipment market. That structural advantage makes its revenue and margin profile more predictable than many other chip-equipment names once a capacity cycle begins.
The market should care because AI model training and inference both scale with compute, and hyperscalers and foundries are investing to expand capacity. That demand translates directly into ASML orders for high-value machines, and into spare-part and service revenue that carries strong gross margins.
Evidence from the numbers
- Q1 performance: the company reported total net sales of 8.8 billion and a 53.0% gross margin, a clear beat on margin quality.
- Guidance lift: management raised full-year 2026 guidance to 36-40 billion in total net sales with a 51-53% gross margin range - a confident, wide-but-elevated view that implies sustained demand through the year.
- Capital returns: management increased the dividend by 17% and reiterated an active buyback program (a 1.1 billion program was noted). The company also repurchased shares in recent weeks, showing management is willing to use free cash flow to reduce shares outstanding.
- Balance/market stats: market capitalization stands at $585,183,989,915, P/E is 53.74 and P/B is 25.10. The high valuations reflect a premium for technology leadership and outsized earnings growth expectations.
- Technicals and sentiment: momentum indicators show strength - 10/21/50-day EMAs and SMAs are rising (EMA 9-day ~1,431; EMA 21-day ~1,394; SMA 50-day ~1,395) and RSI sits near 64.5, suggesting constructive but not yet extreme internals. MACD is signaling bullish momentum with a healthy histogram.
Valuation framing
At a market cap of roughly $585.2 billion and a P/E north of 50, ASML is priced for continued high-single- to double-digit earnings growth. That multiple is steep relative to the broader market, but not unreasonable for a near-monopoly that captures most of the value in the most advanced nodes. The company’s gross margins above 50% and the recurring after-sales service revenue justify a premium, especially if the mid-cycle equipment cadence persists.
Put differently: this is not a deep-value call. You are paying for structural leadership and scale. The question for the next 6-12 months is whether AI-driven capex and node transitions sustain order flow at the elevated levels management now forecasts. The Q1 guide lift and margin strength give that case some traction, but the valuation already bakes in strong execution.
Catalysts to push the stock higher
- Continued order momentum and backlog conversion tied to hyperscaler capacity builds.
- Further buybacks and dividend increases that reduce supply and improve per-share metrics.
- Operational cadence: consistent delivery and service revenue growth that sustains >50% gross margins.
- Industry movements: accelerated node transitions by major foundries and IDM customers that require more advanced lithography tools.
Trade plan (actionable)
My recommended tactical position is a disciplined long with a clearly defined entry, stop and target. This is a position trade designed to capture the next leg of the capacity cycle while limiting downside if demand proves softer than management forecasts.
| Entry | Stop | Target | Horizon |
|---|---|---|---|
| $1,528.46 | $1,400.00 | $1,700.00 | Position trade - long term (180 trading days) |
Rationale: enter at the current market level ($1,528.46) because momentum and fundamentals are aligned; set a stop at $1,400 to respect a logical support band below recent EMAs and to limit downside if the AI capex story stalls; target $1,700 represents meaningful upside while remaining within the realm of achievable multiple expansion or continued earnings beats over a 180-trading-day period.
Horizon detail: this is a position trade designed to last up to 180 trading days (long term - 180 trading days). Expect the trade to play out over several earnings / order-cycle updates and through incremental buyback/delivery announcements. I outline shorter checkpoints below:
- Short term (10 trading days): monitor order announcements and any headline macro events that compress risk appetite. If the stock rejects quickly above current levels, consider trimming into strength.
- Mid term (45 trading days): watch guidance flow and service revenue stabilization; a second consecutive quarter of strong margins would materially de-risk the setup.
- Long term (180 trading days): by this horizon you should see order backlogs, capacity deliveries and the effect of buybacks on EPS. Maintain the position while fundamentals continue to support elevated margins and order rates.
Risks and counterarguments
Every trade has a credible bear case. Here are the main risks and one explicit counterargument to the buy thesis.
- Cyclical demand risk - Equipment spending is lumpy. If hyperscalers pause expansion or shift to more efficient chips that require fewer advanced nodes, order momentum could fall quickly and prices would re-rate lower.
- Geopolitical and supply-chain constraints - Geopolitical tensions or export controls could disrupt deliveries or constrain the company’s ability to serve certain customers, increasing uncertainty about revenue conversion.
- Execution risk - ASML must continue to deliver complex machines on schedule. Any production delays, quality issues or missed shipments would show up quickly in guidance and compress the multiple.
- Valuation vulnerability - The stock trades at premium multiples (P/E ~53.7, P/B ~25.1). If market sentiment shifts and multiples revert toward long-term norms, the share price could decline even with decent underlying growth.
- Macro shocks and liquidity events - Broader market drawdowns or spikes in rates could disproportionately punish high-multiple industrial names; a systemic risk event could create downside regardless of company fundamentals.
Counterargument: One could reasonably argue ASML is fully priced for perfection. The P/E >50 implies expectations for sustained high growth and margin stability; any miss would be punished. If you believe AI capex will falter or that hyperscalers will slow purchases after an initial surge, the prudent stance is to wait for a pullback below $1,300 or for clearer evidence of recurring order flow before initiating a position.
Why I still favor the trade
Despite the high valuation, the economics of advanced lithography create an asymmetric payoff: ASML captures a large share of the value created by cutting-edge chips, and machines are not easily replaceable. The Q1 beat, 53% gross margin and the raised guidance to 36-40 billion in sales for the year are material evidence that demand is present — not just expected. Active buybacks and a 17% dividend increase also show management confidence and willingness to use cash to tighten shares outstanding, which amplifies per-share earnings if sales hold up.
Conclusion - clear stance and what would change my mind
Stance: Long at $1,528.46 for a position trade up to 180 trading days with a stop at $1,400 and a target of $1,700. I view this as a risk-managed way to own exposure to the AI-driven capacity cycle through a company with a defendable technological franchise and high-margin recurring revenue.
What would change my mind: two developments would force me to exit or materially reduce the position - (1) a sustained decline in new orders or an explicit cut to guidance, and (2) any operational failure leading to meaningful delivery delays. Conversely, accelerated buybacks, another dividend raise, or materially better-than-guided orders would strengthen the bull case and justify raising the target.
Execution discipline matters: stick to your stop, size the position so that a stop hit is a manageable loss, and revisit your thesis as the company reports incremental order and delivery data over the coming quarters.